analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of cholangiocarcinoma.
Manju Nidagodu JayakumarJibran Sualeh MuhammadMainak DuttaSainitin DonakondaPublished in: Comput. Biol. Medicine (2023)